News

  1. 11/15/2018 Catalent to Discuss Brexit at Partnerships in Clinical Trials Conference

  2. 11/13/2018 Catalent to Open Second Clinical Supply Facility in China

  3. 11/06/2018 Bioprocessing and Cell Line Development to be Presented at Waterside Conference

  4. 11/01/2018 Anklam Extrakt & Catalent Partner to Provide Relief for Dry Eye Discomfort

  5. 10/30/2018 Catalent to Lead Debate on Developability Classification System at AAPS

  6. 10/17/2018 Patient-Focused Drug Delivery to be Presented by Catalent at PODD

  7. 10/16/2018 Catalent & Verastem Oncology Partner on FDA Approved COPIKTRA

  8. 10/15/2018 Phase-Appropriate Validation of Bioassays to be Presented at WCBBA

  9. 10/11/2018 Catalent Clinical Supply Experts Present at Industry Conferences

  10. 10/04/2018 Catalent Invests $7.3 Million at Aprilia Facility

  11. 09/26/2018 Catalent to Provide Oral Delivery Systems for Parkinson’s Disease Therapies

  12. 09/20/2018 Lipid-Based Drug Delivery Presented by Catalent and BASF

  13. 09/04/2018 Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent

  14. 08/30/2018 Catalent Experts to Discuss Biologics Development and Manufacturing at BPI East

  15. 08/14/2018 Catalent Completes Tender Offer for Juniper Pharmaceuticals, Inc.

  16. 08/09/2018 Catalent Biologics Expert to Discuss Assay Automation at IDDST

  17. 07/17/2018 Catalent Experts at Upcoming Controlled Release Society Conference

  18. 07/12/2018 Catalent Appoints Marlene Leuenberger as General Manager

  19. 07/10/2018 Catalent Biologics Adopts Berkeley Lights’ Beacon® Optofluidic Platform

  20. 07/03/2018 Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

  21. 06/26/2018 Catalent Biologics Appoints New General Manager for Madison, Wisconsin

  22. 06/13/2018 Catalent Appoints Paul Hegwood as New President of Clinical Supply Services

  23. 06/07/2018 Biological Drug Development & Delivery at Catalent Institute / JLABS Symposium

  24. 05/31/2018 Catalent Biologics Supports New Methamphetamine Treatment

  25. 05/17/2018 Catalent Completes $5.5 Million Expansion at Kansas City

  26. 05/14/2018 Catalent Biologics and Valerius Biopharma to Collaborate on Biosimilars

  27. 04/24/2018 Catalent Invest $5 million to Create Drug Development Center of Excellence

  28. 04/19/2018 Catalent to Lead Multiple Workshops at Upcoming US GCSG Conference

  29. 04/12/2018 Catalent Completes $5.5 Million Expansion at Philadelphia Facility

  30. 04/11/2018 Catalent to Present at Upcoming INTERPHEX Convention

  31. 03/08/2018 Catalent To Discuss Potential Implications of Brexit on Clinical Supply

  32. 03/01/2018 Catalent Institute to Host Discussion on Patient-Focused Drug Design

  33. 02/28/2018 Catalent Completes $4.6 Million Expansion at Singapore Facility

  34. 02/22/2018 Catalent to Present at Clinical Trial Supply New England

  35. 02/21/2018 Biohaven Announces Exclusive License with Catalent for Zydis® ODT

  36. 02/05/2018 Catalent Recognized with 10 CMO Leadership Awards

  37. 01/29/2018 Catalent Biologics to Present at CASSS WCBP Symposium

  38. 12/04/2017 Triphase to Present IND Enabling Data for TRPH-222

  39. 11/30/2017 Vaccinex and Catalent Biologics to Collaborate on ADC Development

  40. 11/09/2017 Catalent Present on Drug Delivery, Formulation & Patient-Focused Design at AAPS

  41. 10/30/2017 Catalent & Grid Collaborate to Develop Novel Targeted Immuno-Oncology Therapy

  42. 10/24/2017 Catalent Completes Acquisition of Cook Pharmica

  43. 10/02/2017 FDA Approve Symbiomix’s Solosec™; Follows Four-Year Collaboration with Catalent

  44. 09/25/2017 Catalent to Host Workshops on Bioassay Development at Upcoming Conferences

  45. 09/19/2017 Catalent to Acquire Cook Pharmica for $950 Million

  46. 09/18/2017 Catalent to Lead Informative Sessions at SupplySide West

  47. 09/14/2017 Catalent Invests to Increase Clinical Storage Capacity at Philadelphia Site

  48. 09/05/2017 Catalent Signs Commercial Manufacturing Agreement with US WorldMeds

  49. 07/26/2017 Catalent Applied Drug Delivery Institute Appoints Jim Spavins to Advisory Board

  50. 07/20/2017 Catalent Applied Drug Delivery Institute Partners with Rutgers University

  51. 07/17/2017 Catalent Launches New OptiForm® Solution Suite

  52. 07/12/2017 Pfizer Partners with Catalent for the Manufacture of Advil® Liqui-Gels® Minis

  53. 07/11/2017 Catalent to Host Industry Experts at Controlled Release Society Conference

  54. 06/22/2017 Advancements in Biologics and Fast-Track Development of Low Solubility Compounds

  55. 05/25/2017 Catalent to Host Spray Drying Technology Symposium

  56. 05/15/2017 Catalent Biologics Announces Collaboration with Therachon, Switzerland

  57. 05/11/2017 Catalent to Showcase Expanded Formulation Toolkit and Innovative Technologies

  58. 05/09/2017 Catalent Provides Commercial Manufacturing of Lexicon's XERMELO™

  59. 05/04/2017 Catalent to Launch Innovative Fish Oil Supplement Product at Vitafoods Europe

  60. 05/03/2017 Challenges and Strategies to Automate Potency Assays to be Discussed

  61. 04/27/2017 New Advances to be Presented at Upcoming PEGS Conference

  62. 04/25/2017 Pharmatek Adds Further cGMP Spray Drying Capacity

  63. 04/04/2017 Catalent Expands Kansas City Clinical Storage & Secondary Packaging Capabilities

  64. 03/30/2017 Catalent Expert to Present at ISPE Conference

  65. 03/23/2017 Catalent Wins Prestigious Clinical Supply Chain Excellence Award

  66. 03/21/2017 Catalent Biologics Announces Appointment of Matthew Stober to Advisory Board

  67. 03/16/2017 Catalent Executives to Present at Upcoming BioPharma Asia Conference

  68. 03/14/2017 Catalent Experts to Contribute to Educational Programs at INTERPHEX

  69. 03/07/2017 Challenges & Innovation in Clinical Trial Supply to be Presented by Catalent

  70. 03/02/2017 Workshop Hosted by Catalent Experts at BEBPA Conference

  71. 02/21/2017 Presentation by Catalent Expert at Upcoming Industry Summit

  72. 02/16/2017 Catalent Completes Accucaps Acquisition

  73. 01/31/2017 Catalent to Host Workshop with Leading Biologics Experts

  74. 01/24/2017 Catalent to Showcase Aseptic Filling and Capabilities at Pharmapack

  75. 01/19/2017 Catalent & Gattefossé to present Strategies for Lipid-based Oral Medicines

  76. 01/18/2017 Catalent to Discuss Accelerated Biopharmaceutical Development at WCBP Conference

  77. 01/09/2017 Catalent to Develop Softgel Capsules for JOT’s Leading Orphan Disease Candidates

  78. 12/15/2016 Catalent Biologics Collaborates with PATH Malaria Vaccine Initiative

  79. 12/08/2016 Catalent Becomes First CDMO to Join Pharmaceutical Supply Chain Initiative

  80. 11/29/2016 Catalent to Present at Upcoming Industry Conference

  81. 11/28/2016 Catalent to Acquire Accucaps Expanding Softgel Development & Manufacturing

  82. 11/23/2016 Catalent Celebrates 20 Years at Bolton Facility

  83. 11/17/2016 Catalent Appoints Shannon Trilli in New Role for Corporate Responsibility

  84. 11/11/2016 Catalent Expert to Discuss Evolving and Innovative Logistical Strategies

  85. 11/08/2016 Catalent Experts Present at AAPS Annual Convention

  86. 11/04/2016 Expert Panel To Discuss Integrated Approach To Strategic Drug Development

  87. 10/24/2016 Catalent Celebrates Ground Breaking For Expanded Biologics Facility

  88. 10/20/2016 Catalent Appoints Kunal Jaiswal to VP, Strategic Development for Clinical Supply

  89. 10/19/2016 Catalent Presents Innovative Softgel Developments at OTC Conference in Singapore

  90. 10/18/2016 Catalent To Provide Fill & Finish Services For Commercial Supply

  91. 10/13/2016 Catalent Biologics Announces Agreement With Moderna Therapeutics

  92. 10/05/2016 Catalent Wins Prestigious CPhI Pharma Award at CPhI Worldwide

  93. 10/04/2016 Catalent Biologics & Triphase Accelerator Corporation Announce License Agreement

  94. 09/27/2016 Catalent Showcases Advanced Technologies & Solutions at CPhI Worldwide

  95. 09/21/2016 Catalent Biologics Appoints Director of R&D, Bioanalytical Chemistry

  96. 09/13/2016 Catalent Signed Agreement to Acquire Pharmatek Laboratories

  97. 08/30/2016 Catalent Executives Invited to Speak at Upcoming Conferences

  98. 08/02/2016 Catalent Biologics Collaborates to Develop New & More Efficacious Antibodies

  99. 07/13/2016 Catalent to Present at CRS on Early-Stage Dose Form Optimization & More

  100. 07/05/2016 Catalent Announces Appointment of New General Manager of Australia Facility

  101. 06/30/2016 Catalent Agreement to Commercially Supply Palatin Technologies’ New Product

  102. 06/29/2016 Catalent to Present at Medicinal Chemistry Ireland Conference

  103. 06/27/2016 Catalent Launches FastChain™ Demand Led Clinical Supply Solution

  104. 06/23/2016 Catalent to Discuss Clinical Supply Chain Solutions at DIA 2016 Conference

  105. 06/21/2016 OPKO’s Rayaldee® Product Uses Catalent’s OptiShell® Technology

  106. 06/07/2016 Catalent Expert To Present On Global Cold Chain Clinical Supply Strategies

  107. 06/06/2016 Catalent Opens New Clinical Supply Facility on its Japan Campus

  108. 06/02/2016 Launch of New Platform for Accelerated Development of Biological Drug Molecules

  109. 05/26/2016 Catalent Strengthens Leadership Position in Asia-Pacific

  110. 05/19/2016 Catalent Introduces New Label to Improve Storage & Retrieval of Patient Kits

  111. 04/26/2016 Catalent Wins Prestigious ‘Editor’s Choice’ Award At Interphex

  112. 04/21/2016 Catalent Experts At Upcoming PEGS Conference in Boston

  113. 04/19/2016 Catalent Experts to Discuss Innovative Delivery Technologies at Interphex

  114. 04/15/2016 Catalent to Present at CPhI Japan Conference

  115. 04/13/2016 Catalent Institute Experts to Present at Respiratory Drug Delivery

  116. 04/11/2016 Catalent Executives to Present at Upcoming Asian ISPE Conferences

  117. 03/17/2016 Catalent to Present at Biopharma Asia in Singapore

  118. 03/15/2016 Advances in Biologic Development & Delivery Symposium by Catalent Institute

  119. 03/10/2016 Catalent Biologics to Present at BioProcess International West Conference

  120. 03/07/2016 Catalent Presents Strategies for Integrating Global Cold Chain Supply Networks

  121. 03/02/2016 Catalent To Speak On Patient Perceptions & Clinical Trial Supply Models

  122. 03/01/2016 Acticor Biotech selects GPEx® Technology to develop ACT-017

  123. 02/02/2016 Catalent Invests $4.6M To Further Expand Clinical Trials Hub In Singapore

  124. 02/01/2016 Catalent Presents at IPEC-Europe Conference

  125. 01/28/2016 Catalent & Cerenis Therapeutics Announce Phase III Trial of CER-001

  126. 01/26/2016 Catalent Presents "Overcoming Challenges In Formulation Development" at Informex

  127. 01/21/2016 Catalent Announces Appointment of New Development & Analytical Services VP

  128. 01/19/2016 Catalent to Open New Clinical Supply Facility in Japan

  129. 01/14/2016 Evolving to a More Efficient and Lean Clinical Trial Supply Model

  130. 01/13/2016 Catalent Biologics Collaborates with Roche on SMARTag™ Technology

  131. 12/09/2015 Catalent Biologics Announces Appointment of VP, Business Development & Licensing

  132. 12/07/2015 Pfizer Awards Flagship OTC Product Manufacturing Contract To Catalent

  133. 11/26/2015 Catalent Institute Announces Educational Workshop Series

  134. 11/25/2015 Catalent to Discuss Challenges & Logistics of Clinical Trials in Asia

  135. 11/20/2015 Catalent Biologics Expands Analytical And Process Development Capabilities

  136. 11/16/2015 Catalent Working to Re-Start Production at French Facility

  137. 10/27/2015 Catalent Quadruples Cold Chain Capacity in Shanghai

  138. 10/21/2015 Catalent Announces New President of Clinical Supply Services Business

  139. 10/14/2015 Catalent Wins ‘Innovation In Process & Formulation Development’ Award at CPhI

  140. 10/13/2015 Catalent Announces Appointment Of Vice President Of Science And Technology

  141. 10/01/2015 Catalent Launches Optiform® Solution Suite For Accelerated Drug Development

  142. 09/28/2015 Catalent Quality Expert Invited To Discuss Effective Auditing Strategies

  143. 09/24/2015 Demand Led Supply Model To Improve Clinical Trial Supply Chains

  144. 09/10/2015 Patient-Centric Drug Design & Innovative Technologies Symposium

  145. 08/27/2015 Clinical Trial Supply Chain Logistics Discussed At Upcoming Flypharma Conference

  146. 08/05/2015 Catalent Biologics Announces New Advisory Board

  147. 08/03/2015 OptiShell® Technology for New Chronic Kidney Disease Treatment

  148. 07/28/2015 Catalent, Inc. Appoints J. Martin Carroll to its Board of Directors

  149. 07/23/2015 Applied Drug Delivery Institute Recognizes Innovators with Global Award

  150. 07/22/2015 Catalent Announces Busy Agenda At Controlled Release Society Annual Meeting

  151. 07/07/2015 Catalent Biologics Adds New Technology Platform

  152. 07/02/2015 Catalent Makes Two Key European Appointments In Oral Dose Manufacturing

  153. 06/16/2015 Catalent Expands Packaging Capabilities In Singapore

  154. 05/15/2015 Lipid-Based Solutions to Improve Bioavailability at Drug Delivery Congress

  155. 04/21/2015 Expansion of Glass-Free Injectable Platform with New ADVASEPT™ Lock Technology

  156. 04/20/2015 Catalent Awarded Grant As Part Of Vaccine Research Consortium

  157. 04/15/2015 Catalent Completes Expansion of Complex Oral Solid Manufacturing Facility

  158. 04/14/2015 Catalent To Launch Extension To ADVASEPT™ Technology Range At Interphex

  159. 04/09/2015 Enhanced Solubility and Speed to Market Discussed by Catalent Expert at DDF

  160. 03/30/2015 Catalent Acquires Pharmapak, Australia

  161. 03/20/2015 Catalent to Present Use Of New Technologies At Upcoming Bioassay Conference

  162. 03/16/2015 Catalent Announces New Organization To Speed New Products To Market

  163. 02/26/2015 Catalent Expands Capabilities within European Clinical Supply Services Network

  164. 02/18/2015 Catalent to Present New Data on Benefits of SMARTag™ Technology at World ADC

  165. 02/05/2015 Lipid-Based Solutions Workshop Presented At Drug Delivery & Formulation Summit

  166. 02/02/2015 Catalent to Present Bioavailabity Solutions & Drug Delivery Toolkit at InformEx

  167. 01/28/2015 Catalent Pharma Solutions Further Expands Its High Potency Handling Capability

  168. 01/23/2015 Catalent VP Of Global Operations Wins Program Director Of The Year Award

  169. 01/22/2015 Catalent Expands Coating & Packaging Operations In Eberbach, Germany

  170. 01/19/2015 Catalent Biologics & MGC Pharma Announce Partnership: Biomanufacturing In Asia

  171. 01/14/2015 Catalent & Sanofi To Collaborate On SMARTag™ Antibody-Drug Conjugate Technology

  172. 01/07/2015 Catalent Appoints Two Industry Leaders To Its European Clinical Supply Network

  173. 12/04/2014 Catalent & SELLAS Sign Exclusive Agreement For Therapeutic Reprofiling

  174. 12/02/2014 Catalent and Valerion Collaborate on New Treatments For Orphan Genetic Disorders

  175. 11/13/2014 Catalent Acquires Micron Technologies

  176. 11/03/2014 Catalent Expands Highly Potent And Cytotoxic Clinical Packaging Capabilities

  177. 10/30/2014 Latest Developments in Bioavailability, Drug Delivery & More Presented At AAPS

  178. 10/28/2014 Catalent Appoints Mark Bisset as President, Catalent Asia Pacific

  179. 10/21/2014 ADC Generation Using SMARTag™ Technology Presented At World ADC Congress

  180. 10/14/2014 Catalent Appoints Senior Vice President And General Counsel

  181. 10/08/2014 Catalent and Redwood Bioscience Win Inaugural ‘Innovation In Partnering’ Award

  182. 10/06/2014 Catalent Applied Drug Delivery Institute Collaborates With Lung Cancer Alliance

  183. 10/02/2014 Catalent Acquires Redwood Bioscience Inc. and the SMARTag™ Technology Platform

  184. 09/30/2014 Catalent Announced Full Agenda for 25th Annual CPhI Worldwide Conference

  185. 09/25/2014 Catalent Announces Two Senior Executive Appointments to Its Development Business

  186. 09/24/2014 Catalent and Cingulate Therapeutics Sign Exclusive Agreement

  187. 09/17/2014 New OptiPact™ Technology Introduced By Catalent

  188. 09/15/2014 Best Practices In Risk Mitigation Presented By Catalent At Internal Audit Summit

  189. 09/08/2014 Bioavailability Symposium Announced by Catalent Applied Drug Delivery Institute

  190. 09/04/2014 Catalent Announces Two Senior Appointments To Its Biologics Business

  191. 08/27/2014 Catalent & Minomic Collaborate To Bring New Prostate Cancer Treatment To Market

  192. 08/14/2014 Catalent Confirms Appointment of Two Healthcare Executives to Board of Directors

  193. 07/31/2014 Catalent, Inc. Announces Pricing of Its Initial Public Offering

  194. 07/29/2014 Catalent Expert to Present at Japan Society of Drug Delivery Systems

  195. 07/09/2014 Nine Catalent Experts to Present on Industry Challenges & Drug Delivery at CRS

  196. 07/01/2014 Catalent Marks 40 Years in Japan with New Investments and Country Leader

  197. 06/26/2014 FDA Invites Catalent to Present on New Drug Delivery Technologies

  198. 06/24/2014 New Study: Decreased Mortality & Better Tolerability of ADC w/ SMARTag Platform

  199. 06/19/2014 Latest Developments in ADC Presented by Catalent and Redwood Biosciences at BIO

  200. 06/16/2014 Creating A Culture of Operational Excellence Presented at European Summit

  201. 06/11/2014 Annual Competition Recognizes Talent In Graduate Pharmaceutical Programs

  202. 05/07/2014 Innovation Symposium Announced By Catalent Applied Drug Delivery Institute

  203. 05/02/2014 Oral Drug Delivery Formulation Techniques Showcased At Recent Event

  204. 04/30/2014 Continual Performance Monitoring Of Potency Assays Presented At IBC Conference

  205. 04/02/2014 New Drug Delivery Technologies to be Presented by Catalent Experts at ICSE Japan

  206. 03/24/2014 Catalent Increases Stake In Redwood Bioscience

  207. 03/17/2014 Catalent Celebrates 80 Years of Softgel Innovation at Interphex

  208. 03/11/2014 Catalent Launches ADVASEPTTM For Glass-Free Delivery Of Injectable Drugs

  209. 03/10/2014 Use Of QbD To Mitigate Risk In Aseptic Fill/Finish Presented At PDA Conf

  210. 03/06/2014 Catalent Announces Agreement For One Of The First Regenerative Therapies

  211. 02/26/2014 Catalent Announces Two Senior Appointments To Expand Biologics Business

  212. 02/17/2014 Catalent and Redwood Bioscience to Present on Next Generation Drug Conjugates

  213. 02/10/2014 Improved Drug Delivery in Animal Health Presented by Catalent Experts

  214. 02/06/2014 Leading Industry & Academic Experts to Discuss Drug Delivery Technologies

  215. 02/04/2014 Catalent Demonstrates Process Excellence During PEX Week

  216. 01/24/2014 Catalent Files Registration Statement For Initial Public Offering

  217. 01/24/2014 New Technologies and QbD Concepts to be Discussed at Forthcoming Events

  218. 01/23/2014 3rd Annual Global Academic Competition for Life Science Leaders of Tommorrow

  219. 01/07/2014 Catalent and Adamas Pharmaceuticals Enter Into Phase III Manufacturing Agreement

  220. 12/09/2013 Orphan Drug Model to be Debated by Catalent Expert at FDA/CMS Summit

  221. 12/08/2013 Extractables and Leachables for Parenteral and Opthalmic

  222. 12/05/2013 Catalent & Redwood Bioscience present Next Generation Antibody Drug Conjugates

  223. 11/20/2013 Pharmacyclics and Catalent Solidify Partnership on Imbruvica™

  224. 11/19/2013 Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal

  225. 11/11/2013 Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business

  226. 11/06/2013 New Interactive Web Tool Helps Innovators

  227. 11/04/2013 New Drug Delivery Technologies Presented at AAPS

  228. 10/16/2013 Catalent Presents New Technologies at CPhI

  229. 10/14/2013 Compelling New Data on Next Generation Antibody Drug Conjugates

  230. 10/08/2013 Catalent Acquires Relthy to Expand South American Softgel Business

  231. 09/25/2013 Catalent Announces Expansion of Optimelt™ Hot Melt Extrusion

  232. 09/22/2013 Catalent Participates in Inaugural Blackstone Veterans Hiring Summit

  233. 09/19/2013 The Institute Appoints Professor Claus-Michael Lehr to Advisory Board

  234. 09/16/2013 Catalent Pharma Solutions and Supernus Partner for Supply of Trokendi XR™

  235. 09/11/2013 Catalent Experts to Present Collaborative Product Development at EPTM

  236. 09/08/2013 Catalent Appoints First President of Asia Pacific

  237. 09/03/2013 Catalent Applied Drug Delivery Institute Announces European Educational Event

  238. 07/15/2013 Advances in Modified & Controlled Release - Catalent at 40th Annual CRS Meeting

  239. 07/09/2013 Catalent and Biota Pharmaceuticals Expand Their Alliance

  240. 07/07/2013 Catalent Creates New Advanced Delivery Technologies Business Unit

  241. 06/11/2013 Catalent Breaks Ground of its Winchester, KY CR Manufacturing Facility

  242. 05/15/2013 Worldwide Competition Recognizes Next-Generation Scientific Talent

  243. 05/12/2013 Catalent Wins Two Prestigious Process Excellence Awards

  244. 05/09/2013 Omega-3 Trends and Innovations at Vitafoods

  245. 04/24/2013 Catalent Announces Opening of New Single-Use Biomanufacturing Center

  246. 04/22/2013 Company Receives Two PEX Network European Awards Nominations

  247. 04/18/2013 Catalent Experts Exhibit and Present at BIO and Interphex 2013

  248. 04/15/2013 Catalent Announces Two Senior Appointments to Drive Growth in China

  249. 04/09/2013 Catalent Biologics Expands Into ADCs Through Exclusive License

  250. 03/25/2013 catalent leader to chair discussions on optimizing clinical operation in china

  251. 03/19/2013 Catalent Australia and Medipharm Partner to Supply Malaysian Market

  252. 03/18/2013 Experts Consider Challenging Tech Transfers at Dusseldorf Pharma Congress

  253. 03/06/2013 Applied Drug Delivery Institute Welcomes Accomplished Life Sciences Leader

  254. 03/04/2013 Catalent Quality Development Leader to Present at China Clinical Trials

  255. 02/25/2013 Speeding Drug Development Through Use of High Yield Stable GPEx® Technology

  256. 02/24/2013 Catalent Presents Drug Delivery Strategies at Improving Solubility in Philly

  257. 01/29/2013 Catalent Applied Drug Delivery Institute Holds 2nd Global Academic Competition

  258. 01/28/2013 The Impact of Emerging Bioassay Technologies Presented at WCBP Conference

  259. 01/22/2013 Presenting Better Treatments Through Bioavailability Enhancement

  260. 01/21/2013 Accelerating Development from CDNA Sequence to Master Cell Bank Candidate

  261. 01/09/2013 Catalent Makes Investment to Expand Inhalation Capabilities in RTP, NC

  262. 01/07/2013 Catalent and Aegerion Partner on Launch of Newly FDA Approved Juxtapid™

  263. 12/12/2012 Catalent and UMN Pharma announce collaboration for production in Japan

  264. 12/12/2012 Bio-Process Systems Alliance Elects New Director from Catalent

  265. 12/06/2012 Catalent to supply the newly approved Exelixis COMETRIQ™

  266. 11/27/2012 Oral Drug Delivery for Macromolecules Using Softgel Lipid Delivery System

  267. 11/25/2012 Faster Pipeline Progression Discussed by Catalent Expert EAC 2012

  268. 11/19/2012 Catalent Experts to Speak at Pharma Integrates 2012

  269. 11/12/2012 Catalent Announces Cell Line Sales Agreement with CEVEC Pharmaceuticals

  270. 11/08/2012 Extractable and Leachables for Biological and High Risk Dosage Forms

  271. 10/16/2012 Catalent Wins Fifth Consecutive European Outsourcing Award

  272. 10/15/2012 Catalent Announces Launch of Catalent Applied Drug Delivery Institute

  273. 10/09/2012 Catalent Licenses Technology with NJIT

  274. 10/07/2012 Catalent Present at the 2012 AAPS Annual Meeting

  275. 10/01/2012 Catalent Announces Global Alliance with PAREXEL

  276. 09/30/2012 Catalent Enters Into Commerical Supply Agreement with Vivus

  277. 09/19/2012 Catalent Expert Invited to Speak on Advanced Delivery Technologies

  278. 09/17/2012 Optimizing Clinical Supply Processes and Maximizing Budgets Presented

  279. 09/17/2012 Catalent Completes $350 Million 7.875% Senior Notes Offering

  280. 09/12/2012 Catalent and CTC Partner to Help Korean Pharma

  281. 09/05/2012 Catalent Quality Expert Presents At 2012 ICH Q10 Workshop

  282. 07/23/2012 Catalent Announces Commencement of Supply of Abilify®

  283. 07/18/2012 Expert Invited to Speak on the Advantages of Single Use Biomanufacturing

  284. 07/17/2012 Catalent Expert Will Present at PERI

  285. 07/10/2012 Catalent Expert Presents at 2012 CRS Conference

  286. 06/21/2012 Catalent Experts Present at CPhI/ICSE China 2012

  287. 06/20/2012 Catalent and Bend Provide Solutions for Controlled-Release Technologies

  288. 06/19/2012 Frazier Healthcare Acquires Packaging Operations from Catalent Pharma Solutions

  289. 06/10/2012 Catalent Expert Conducts Workshop On Solid Dosage Forms

  290. 06/04/2012 Catalent Increases Sterile Fill-Finish Manufacturing Capacity

  291. 05/29/2012 Catalent Enters Agreement to Sell Its U.S. Commercial Packaging Operations

  292. 05/15/2012 Catalent Announces Winners of Global Academic Competion

  293. 05/13/2012 Drug Delivery/Formulation Issues Identified As Concerns In Technology Survey

  294. 05/10/2012 Catalent Expert Gives Working Group Update At Conference

  295. 04/29/2012 Biosimilars Webinar Presented by Catalent Expert

  296. 04/26/2012 Case Study Presented on Achieving Biological Assay Success

  297. 04/16/2012 Catalent Expert Presents at German Pharma Congress

  298. 04/15/2012 Nascent and Catalent Sign Cancer Antibody Development Deal

  299. 04/11/2012 Two Global Catalent Experts Present at AAPS Workshop

  300. 04/10/2012 Catalent Expert To Share Formulation Development Expertise at Aerosol School

  301. 04/09/2012 Catalent Expert to Present at ISPE Japan 2012

  302. 04/03/2012 BASF and Catalent Join Forces to Solve Bioavailability Challenges

  303. 04/02/2012 Catalent Expert Presents Case Study at PDA

  304. 03/29/2012 Pharma Industry in NJ: A Panel Discussion

  305. 03/21/2012 Catalent Extends Development and Analytical Solutions Capabilities in UK

  306. 03/14/2012 Catalent Experts To Present Drug Delivery Technologies At ICSE/CPhI Japan 2012

  307. 03/11/2012 Catalent Appoints a Vice President of Commercial Excellence

  308. 03/07/2012 Expert Presents At The 5th Annual Comparator Studies Conference

  309. 03/06/2012 Catalent Continues Investment In Global Clinical Supply Services

  310. 03/01/2012 Drug Delivery Innovations Presented at 2nd Lyophilization Americas Conference

  311. 02/28/2012 Catalent Acquires 100% of R.P. Scherer - Eberbach, Germany

  312. 02/20/2012 Catalent Expert Presents on Protein Expression in CHO Cells

  313. 02/19/2012 Catalent Expert Presents Effective Global Supply Chain Solutions

  314. 02/16/2012 Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit

  315. 02/15/2012 Catalent and NewMarket Pharmaceuticals to Develop Better Treatments

  316. 01/31/2012 Expansion Advanced Dose Form Facility In Italy Complete

  317. 01/29/2012 Catalent Acquires Current Minority Interest in R.P. Scherer, Eberbach, Germany

  318. 01/24/2012 Catalent Expands Controlled Release Drug Development & Supply

  319. 01/18/2012 Catalent Expert To Present On Virological Safety

  320. 01/17/2012 Catalent Expert To Present On Technology Delivery

  321. 01/15/2012 Catalent Expert to Present Strategies for Improved Oral Delivery

  322. 01/03/2012 Catalent Expert to Present at Peptalk 2012

  323. 12/06/2011 Catalent Plans to Increase Biologic Development and Manufacturing Capabilities

  324. 11/30/2011 Catalent Expert to Present Strategies to Support Intelligent Global Sourcing

  325. 11/08/2011 New Vice President and General Manager of Sterile Technologies Appointed

  326. 11/02/2011 Catalent Expert To Discuss The Effect of Immunoglobulin

  327. 11/01/2011 Catalent Joins Inhalation Experts to Advance Industry Science

  328. 10/19/2011 Catalent Focus On Expansion and New Technologies at ICSE/CPhI

  329. 10/16/2011 Catalent Highlight New Drug Delivery Technologies and Scientific Expert Events

  330. 10/05/2011 Catalent Expands Analytical Services Capabilities With A New Lab in Swindon, UK

  331. 09/27/2011 Catalent Expert to Present A Case Study of A Phase III Trial

  332. 09/26/2011 Expert to Present Technology Solutions for Biologics Challenges

  333. 09/25/2011 Catalent Expert Presents On Practical Considerations for Bioassays

  334. 09/22/2011 Catalent to Present Webinar on Applied Drug Delivery

  335. 09/20/2011 New VP Business Development, Zydis® Technology, Appointed

  336. 09/20/2011 Catalent and Toyobo Team Up To Launch GPEx®

  337. 09/19/2011 Catalent Announces Partnership With Toyobo Biologics, Inc.

  338. 09/13/2011 Catalent Expansions Show Close Pharma-Biz Tracking

  339. 09/12/2011 Catalent Announces Expansion of Its Advanced Dose Form Facility in Italy

  340. 09/11/2011 Expert to Present at 4th Annual Drug Repositioning Conference

  341. 09/07/2011 Catalent Expert Presents On Viral Safety

  342. 08/21/2011 Catalent to Acquire Aptuit LLC's Clinical Trial Supplies Business

  343. 08/14/2011 Catalent Expert Elsevier Webinar on Biosimiliars and Biobetters

  344. 08/07/2011 Catalent Expert Presents at 3rd Annual FDA Supplier Quality Management Congress

  345. 08/02/2011 Catalent Announces Cold-Chain Expansions to Meet Increasing Customer Demand

  346. 07/27/2011 Catalent Expert Presents New Technologies at 38th Annual CRS Conference

  347. 07/13/2011 Novel OSDrC® Optimized Dosing Technology Introduced

  348. 07/04/2011 Catalent Expert To Present Webinar On Biosimilars and Biobetters

  349. 06/29/2011 Catalent Invests In Global Clinical Suppy Services Capacity and Offering

  350. 06/28/2011 New Medication Delivery Solutions President Appointed

  351. 06/22/2011 Catalent Experts Present at HBA Global Expo 2011

  352. 06/22/2011 Catalent Presents At 7th Annual Improving Solubility Summit

  353. 06/15/2011 CEVEC and Catalent Offer Joint Cell Line Development Service

  354. 06/10/2011 Drug Delivery Trends and Topics With Catalent VP of Strategy

  355. 05/16/2011 Catalent’s Patient Adherence Packaging Design Honored

  356. 05/08/2011 Catalent Expert Presents the Requirements and Importance of Viral Safety

  357. 05/03/2011 New Vice President of Scientific Affairs Appointed

  358. 05/01/2011 Study Shows Adherence Packaging Solutions Drives Gains in Patient Persistency

  359. 04/13/2011 Catalent Announces New Sales Leadership Appoinments

  360. 03/22/2011 Catalent Presents at the 5th Annual Improving Solubility Conference

  361. 03/20/2011 Catalent to Present at INTERPHEX 2011

  362. 03/17/2011 Catalent Appoints New Vice President/General Manager of Consumer Health Softgel

  363. 03/13/2011 Catalent Pharma Solutions Appoints New Senior Vice President of Human Resources

  364. 03/09/2011 Catalent's Schorndorf Facility Celebrates 50 Years

  365. 03/08/2011 Catalent Expert to Teach Drug Development at Institute

  366. 03/08/2011 Catalent Expert Speaks on the Future of Biologics

  367. 02/27/2011 Catalent agrees to sell Printed Components business

  368. 02/16/2011 Catalent Experts Featured At PQRI Workshop

  369. 02/14/2011 Catalent Acquires Exclusive Rights to Lyopan® Fast-Dissolve Technology

  370. 02/02/2011 Catalent to present Efficient Solid-State Screening Using FT-Raman Spectroscopy

  371. 01/30/2011 Catalent Announces Partnership with Nuron Biotech for Phase III Clinical Study

  372. 01/23/2011 Catalent Expert to Present Drug Delivery Solutions to Enhance Bioavailability

  373. 01/18/2011 Catalent Experts to Present Webinar on Fit-For-Purpose Strategies for Solid-Form

  374. 01/16/2011 Catalent Clinical Supply Services Enhances Direct Global Comparator Sourcing...

  375. 01/13/2011 Catalent Expert Delivers US Pharmacopeia Update at 10th Annual Europe Conference

  376. 01/09/2011 Catalent Appoints New Leadership Talent in Global Manufacturing Sites

  377. 01/04/2011 Catalent Clinical Supply Continues to Invest in Automation to Drive High ...

  378. 12/20/2010 Microbiology and Sterility in Pharmaceuticals and Medical Devices

  379. 12/09/2010 Lean Pharma Product Development

  380. 12/08/2010 Catalent Strengthens and Expands

  381. 12/07/2010 Catalent Scientists to Chair

  382. 12/01/2010 Catalent Vice President Shares

  383. 11/10/2010 Catalent Expert to Present

  384. 11/03/2010 Catalent Provides a Simplified

  385. 11/01/2010 Nine Catalent Experts to Present

  386. 10/27/2010 Senior Director of Biotechnology

  387. 10/26/2010 Catalent Appoints New Global

  388. 10/25/2010 Catalent Receives Award

  389. 10/12/2010 Catalent's Eberbach, Germany Site

  390. 10/10/2010 Catalent Expert Leads Workshop

  391. 10/03/2010 Catalent R&D Director Appointed

  392. 09/13/2010 Catalent to Present Ground-Breaking

  393. 09/08/2010 Catalent Softgel Expert to Present

  394. 08/23/2010 Catalent Provides Sunesis

  395. 08/23/2010 Catalent Pharma Solutions Provides Manufacturing and Packaging Expertise

  396. 08/08/2010 World-Class Optiform™ Compound

  397. 07/25/2010 Catalent Scientists to Present

  398. 07/22/2010 Catalent Principal Scientists

  399. 07/20/2010 Catalent Pharma Solutions Adds Pharma

  400. 07/14/2010 Catalent Expert Appointed as Chair

  401. 06/27/2010 Catalent Expert Appointed

  402. 06/27/2010 Catalent Director of Research

  403. 06/21/2010 TraceLink and Catalent Deliver

  404. 06/15/2010 Catalent Joins Business Ethics

  405. 06/13/2010 Senior Director of Biotechnology

  406. 06/10/2010 Catalent Pharma Solutions

  407. 06/09/2010 Catalent Expert Presenting

  408. 06/09/2010 Catalent to Exhibit

  409. 05/10/2010 Catalent Scientists to Present

  410. 05/10/2010 Catalent Announces Lead

  411. 05/09/2010 Catalent Appoints New Vice President

  412. 05/02/2010 Catalent Pharma Solutions

  413. 03/24/2010 Catalent Formulation Expert

  414. 03/22/2010 Catalent Appoints Two

  415. 03/10/2010 Catalent to Present Webinar

  416. 02/17/2010 Catalent Scientist to Co-Chair

  417. 02/10/2010 Catalent Scientist to Present at 2010

  418. 02/01/2010 Catalent Pharma Solutions Appoints

  419. 01/31/2010 Catalent Adds Potent Drug

  420. 01/13/2010 Catalent Expands Packaging Capacity

  421. 01/10/2010 Catalent Solidifies Inhalation

  422. 11/23/2009 Catalent Appoints New Vice President of Global Sales

  423. 11/15/2009 Catalent's Printed Components Plant in Dublin is the First Secondary

  424. 11/04/2009 Catalent Pharma Solutions Enters a Strategic Alliance with Endotis Pharma

  425. 11/03/2009 Catalent Expands Capabilities in Testing for Melamine in Food

  426. 11/02/2009 FDA Approves New Salix Product Exclusively in Catalent's Zydis®

  427. 11/02/2009 Catalent to Present at American Association of Pharmaceutical Scientists Meeting

  428. 10/22/2009 Catalent Develops New Decorin Molecule Form, Strikes Deal With Euclid

  429. 10/19/2009 Catalent Wins Outsourcing Award

  430. 10/18/2009 Catalent Offers the Anti-Counterfeiting DigiTrack™ Digital Watermarking System

  431. 10/06/2009 Catalent Pharma Solutions German Facility Successfully Completes FDA Audit

  432. 10/05/2009 Catalent Pharma Solutions' United Kingdom Packaging Site Receives High

  433. 09/27/2009 Catalent Pharma Solutions Appoints New Sterile Segment President

  434. 09/23/2009 Catalent and GlaxoSmithKline Extend Contractual Agreement

  435. 08/30/2009 Catalent's New Digital Offset Press Reduces Lead Times for Printed Components

  436. 08/19/2009 Catalent Pharma Solutions Creates New Development & Clinical Services Segment

  437. 08/18/2009 Catalent Pharma Solutions Buenos Aires Facility Successfully Completes First FDA Audit

  438. 08/12/2009 Catalent Receives "Preferred Partner Award in Technology" from Wyeth

  439. 06/24/2009 Catalent Pharma Solutions Appoints New Senior Vice President

  440. 05/31/2009 Catalent Pharma Solutions Appoints New Senior Vice President

  441. 05/04/2009 Catalent Pharma Solutions Supports Global Industry Response

  442. 04/30/2009 Catalent Brings Innovative Printing Technology

  443. 04/08/2009 Catalent Pharma Solutions Celebrates 75 Years of Softgel Innovation in 2009

  444. 03/30/2009 BAVARIA Industriekapital AG Announces Acquisition of Osny

  445. 03/17/2009 Catalent Pharma Solutions Announces Printed Components

  446. 03/04/2009 Catalent Pharma Solutions Appoints New President and Chief Executive Officer